Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Evofem Biosciences Inc (NQ: EVFM )

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Aug 10, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open -
Bid (Size) 0.4405 (85)
Ask (Size) 0.4450 (126)
Prev. Close 0.4782
Today's Range N/A - N/A
52wk Range N/A - N/A
Shares Outstanding 100,328,686
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
EVFM Stock Earnings: Evofem Biosciences Reported Results for Q1 2024
Evofem Biosciences just reported results for the first quarter of 2024. 
Via InvestorPlace
InvestorNewsBreaks – Aditxt Inc.’s (NASDAQ: ADTX) Merger Target Expects ‘Fourth Consecutive Year of Net Sales Growth’
Via Investor Brand Network

Performance

More News

Read More
EVFM Stock Earnings: Evofem Biosciences Reported Results for Q4 2023
Via InvestorPlace
InvestorNewsBreaks – Aditxt Inc.’s (NASDAQ: ADTX) Acquisition Target Reports Increased Product Sales, Ongoing Revenue Growth
Via Investor Brand Network
Why Is Evofem (EVFM) Stock Up 85% Today?
Via InvestorPlace
Evofem Biosciences's Return On Capital Employed Insights
Via Benzinga
Evofem Biosciences Return On Capital Employed Overview
Via Benzinga
InvestorNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Potential Acquisition Releases FY 2023 Preliminary Financial Report
Via Investor Brand Network
EVOFEM BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Evofem Biosciences, Inc. - EVFM
From Kahn Swick & Foti, LLC
Via Business Wire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Eagle Bulk Shipping Inc. (NYSE - EGLE), Icosavax, Inc. (Nasdaq - ICVX), Evofem Biosciences, Inc. (OTC - EVFM), CapStar Financial Holdings, Inc. (Nasdaq – CSTR)
From Brodsky & Smith LLC
Via GlobeNewswire
InvestorNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Announces Definitive Agreement to Acquire Evofem Biosciences Inc.
Via Investor Brand Network
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Eagle Bulk Shipping Inc. (NYSE - EGLE), Icosavax, Inc. (Nasdaq - ICVX), Evofem Biosciences, Inc. (OTC - EVFM), CapStar Financial Holdings, Inc. (Nasdaq – CSTR)
From Brodsky & Smith LLC
Via GlobeNewswire
Why Is Life Sciences-Focused Aditxt Stock Trading Higher Today?
Via Benzinga
EVFM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Evofem Biosciences, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
Aditxt, Inc. Enters into Definitive Agreement to Acquire Evofem Biosciences, Inc., Creator of Phexxi®, the First and Only FDA-Approved Hormone-Free Contraceptive Gel, to Address Diverse Reproductive Health Needs of Women Globally
From Aditxt, Inc.
Via Business Wire
CapitalGainsReport: Thursday’s OTC Watchlist (EVFM, EPAZ, NWBO, VDRM)
Via News Direct
Evofem Biosciences Inc. (OTC:EVFM): Here Are Latest News & Updates
Via News Direct
OTC Market Group's Most Active List In November: A Dive Into The Names Experiencing Volume Changes
Via Benzinga
Why Evofem Biosciences Shares Are Plunging Today?
Via Benzinga
4 Analysts Have This to Say About Evofem Biosciences
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 13, 2022
Via Benzinga
Why Invitae Climbed Around 279%; Here Are 98 Biggest Movers From Yesterday
Via Benzinga
Evofem Biosciences Phase 3 EVOGUARD Trial Puts October Catalyst In Play, Here’s Why Investors Are Paying Attention ($EVFM)
Via AB Newswire
Why Verona Pharma Is Trading Higher By Around 84%, Here Are 85 Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Why Avalo Therapeutics Surged 32%; Here Are 111 Biggest Movers From Yesterday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.